Analyze Diet
Frontiers in veterinary science2021; 8; 676774; doi: 10.3389/fvets.2021.676774

Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity.

Abstract: Septic arthritis causes significant morbidity and mortality in veterinary and human clinical practice and is increasingly complicated by multidrug-resistant infections. Intra-articular (IA) antibiotic administration achieves high local drug concentrations but is considered off-label usage, and appropriate doses have not been defined. Using an equine joint model, we investigated the effects of amikacin injected at three different doses (500, 125, and 31.25 mg) on the immune and cartilage responses in tibiotarsal joints. Synovial fluid (SF) was sampled at multiple time points over 24 h, the cell counts determined, and amikacin concentrations measured by liquid chromatography-mass spectrometry. Cytokine concentrations and collagen degradation products in SF were measured by ELISA and multiplex immunoassays. The mean amikacin concentrations in SF were greater than or equal to the minimum inhibitory concentration (MIC) (0.004 mg/ml) for most common equine joint pathogens at all time points tested to 24 h for all three amikacin doses evaluated. The inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) increased significantly in SF in the highest amikacin dose group, despite the fact that increases in SF cell counts were not observed. Similarly, the biomarkers of cartilage type II collagen cleavage (C2C and C12C) were increased in SF following amikacin injection. Mechanistically, we further demonstrated using studies that chondrocytes and synoviocytes killed by exposure to amikacin underwent apoptotic cell death and were phagocytosed by macrophages in a non-inflammatory process resembling efferocytosis. Neutrophils and T cells were susceptible to amikacin cytotoxicity at clinically relevant doses, which may result in blunting of cellular inflammatory responses in SF and account for the lack of increase in total nucleated cell counts following amikacin injection. In summary, decisions on whether to inject cytotoxic antibiotics such as aminoglycosides intra-articularly and what doses to use should take into account the potential harm that antibiotics may cause and consider lower doses than those previously reported in equine practice.
Publication Date: 2021-05-21 PubMed ID: 34095281PubMed Central: PMC8175670DOI: 10.3389/fvets.2021.676774Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper analyses the effects of different doses of intra-articular amikacin, a type of antibiotic, in a horse joint model to address septic arthritis, a major concern in veterinary and human health exacerbated by rising multidrug-resistant infections.

Study Overview

  • The study explored the impacts of three varying dosages of amikacin (500, 125, and 31.25 mg) on immune and cartilage responses in equine tibiotarsal joints.
  • Intra-articular (IA) antibiotic administration was used to achieve high local drug concentrations. This is generally considered off-label usage with unclear standard doses.

Data Collection and Analysis

  • Synovial fluid (SF) was sampled at multiple intervals across 24 hours, and cell counts and amikacin concentrations were determined through liquid chromatography-mass spectrometry.
  • Cytokine concentrations and collagen degradation products were measured through ELISA (enzyme-linked immunosorbent assay) and multiplex immunoassays.

Findings of the Study

  • The mean concentration of amikacin in SF was adequate against most common joint pathogens in horses at all examined time points up to 24 hours for all three amikacin doses.
  • The inflammatory cytokines TNF-α (tumor necrosis factor-alpha) and IL-1β (interleukin-1 beta) increased in SF with the highest dose of amikacin. However, there was no corresponding increase in SF cell counts.
  • Similarly, amikacin injection led to an increase in biomarkers of cartilage type II collagen cleavage, such as C2C and C12C.
  • The research also illustrated that chondrocytes and synoviocytes exposed to amikacin led to cell death via apoptosis and were cleaned up by macrophages in a non-inflammatory process known as efferocytosis.
  • Dangerously, neutrophils and T cells showed susceptibility to amikacin cytotoxicity at doses typical in clinical settings, possibly leading to a reduction of cellular inflammatory responses in SF.

Conclusion and Recommendations

  • The findings suggest that when deciding to use cytotoxic antibiotics like aminoglycosides intra-articularly, potential harms need to be assessed, and lower doses than those generally practiced in equine practice should be considered.

Cite This Article

APA
Pezzanite L, Chow L, Hendrickson D, Gustafson DL, Russell Moore A, Stoneback J, Griffenhagen GM, Piquini G, Phillips J, Lunghofer P, Dow S, Goodrich LR. (2021). Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity. Front Vet Sci, 8, 676774. https://doi.org/10.3389/fvets.2021.676774

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 8
Pages: 676774
PII: 676774

Researcher Affiliations

Pezzanite, Lynn
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Chow, Lyndah
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Hendrickson, Dean
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Gustafson, Daniel L
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Russell Moore, A
  • Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Stoneback, Jason
  • Department of Orthopedic Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
Griffenhagen, Gregg M
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Piquini, Gabriella
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Phillips, Jennifer
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Lunghofer, Paul
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Dow, Steven
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
  • Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Goodrich, Laurie R
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 54 references
  1. Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults.. Lancet 2010 Mar 6;375(9717):846-55.
    doi: 10.1016/S0140-6736(09)61595-6pubmed: 20206778google scholar: lookup
  2. Morton AJ. Diagnosis and treatment of septic arthritis.. Vet Clin North Am Equine Pract 2005 Dec;21(3):627-49, vi.
    doi: 10.1016/j.cveq.2005.08.001pubmed: 16297725google scholar: lookup
  3. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis.. Rheumatology (Oxford) 2001 Jan;40(1):24-30.
    doi: 10.1093/rheumatology/40.1.24pubmed: 11157138google scholar: lookup
  4. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.. Clin Microbiol Rev 2015 Jul;28(3):603-61.
    doi: 10.1128/CMR.00134-14pmc: PMC4451395pubmed: 26016486google scholar: lookup
  5. Tande AJ, Patel R. Prosthetic joint infection.. Clin Microbiol Rev 2014 Apr;27(2):302-45.
    doi: 10.1128/CMR.00111-13pmc: PMC3993098pubmed: 24696437google scholar: lookup
  6. Nair R, Schweizer ML, Singh N. Septic Arthritis and Prosthetic Joint Infections in Older Adults.. Infect Dis Clin North Am 2017 Dec;31(4):715-729.
    doi: 10.1016/j.idc.2017.07.013pubmed: 29079156google scholar: lookup
  7. Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991.. Ann Rheum Dis 1999 Apr;58(4):214-9.
    doi: 10.1136/ard.58.4.214pmc: PMC1752863pubmed: 10364899google scholar: lookup
  8. Geirsson AJ, Statkevicius S, Víkingsson A. Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections.. Ann Rheum Dis 2008 May;67(5):638-43.
    doi: 10.1136/ard.2007.077131pmc: PMC2563417pubmed: 17901088google scholar: lookup
  9. Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, Dijkmans BA. Incidence and sources of native and prosthetic joint infection: a community based prospective survey.. Ann Rheum Dis 1997 Aug;56(8):470-5.
    doi: 10.1136/ard.56.8.470pmc: PMC1752430pubmed: 9306869google scholar: lookup
  10. Edwards CJ, Cooper C, Fisher D, Field M, van Staa TP, Arden NK. The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis.. Arthritis Rheum 2007 Oct 15;57(7):1151-7.
    doi: 10.1002/art.23003pubmed: 17907232google scholar: lookup
  11. Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussiére JL, Sauvezie B. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period.. Ann Rheum Dis 2002 Mar;61(3):267-9.
    doi: 10.1136/ard.61.3.267pmc: PMC1754020pubmed: 11830437google scholar: lookup
  12. Sedrish S, Moore R, Barker S. Pharmacokinetics of single dose intra-articular administration of amikacin in the radiocarpal joints of normal horses. Proceedings of the American College of Veterinary Surgeons Meeting Chicago, Illinois (1994). p. 437.
  13. Orsini JA, Soma LR, Rourke JE, Park M. Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.. J Vet Pharmacol Ther 1985 Jun;8(2):194-201.
  14. Taintor J, Schumacher J, DeGraves F. Comparison of amikacin concentrations in normal and inflamed joints of horses following intra-articular administration.. Equine Vet J 2006 Mar;38(2):189-91.
    doi: 10.2746/042516406776563233pubmed: 16536391google scholar: lookup
  15. Lloyd KC, Stover SM, Pascoe JR, Baggot JD, Kurpershoek C, Hietala S. Plasma and synovial fluid concentrations of gentamicin in horses after intra-articular administration of buffered and unbuffered gentamicin.. Am J Vet Res 1988 May;49(5):644-9.
    pubmed: 2840005
  16. Werner LA, Hardy J, Bertone AL. Bone gentamicin concentration after intra-articular injection or regional intravenous perfusion in the horse.. Vet Surg 2003 Nov-Dec;32(6):559-65.
  17. Dogan M, Isyar M, Yilmaz I, Bilir B, Sirin DY, Cakmak S, Mahirogullari M. Are the leading drugs against Staphylococcus aureus really toxic to cartilage?. J Infect Public Health 2016 May-Jun;9(3):251-8.
    doi: 10.1016/j.jiph.2015.10.004pubmed: 26603270google scholar: lookup
  18. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro.. Clin Orthop Relat Res 1996 Dec;(333):245-51.
  19. Whiteside LA, Roy ME, Nayfeh TA. Intra-articular infusion: a direct approach to treatment of infected total knee arthroplasty.. Bone Joint J 2016 Jan;98-B(1 Suppl A):31-6.
    doi: 10.1302/0301-620X.98B.36276pubmed: 26733638google scholar: lookup
  20. Peppers M, Whiteside L, Lazear R, Roy M. Vancomycin injected in the knee achieved high synovial fluid concentration with a half-life of 3.4 hours. Proceedings, Orthopedic Research Society Long Beach, CA: (2011).
  21. Whiteside LA, Roy ME. One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THA.. Clin Orthop Relat Res 2017 Feb;475(2):419-429.
    doi: 10.1007/s11999-016-4977-ypmc: PMC5213931pubmed: 27511201google scholar: lookup
  22. Pezzanite L, Chow L, Soontararak S, Phillips J, Goodrich L, Dow S. Amikacin induces rapid dose-dependent apoptotic cell death in equine chondrocytes and synovial cells in vitro.. Equine Vet J 2020 Sep;52(5):715-724.
    doi: 10.1111/evj.13243pubmed: 31997397google scholar: lookup
  23. Pezzanite L, Chow L, Piquini G, Griffenhagen G, Ramirez D, Dow S, Goodrich L. Use of in vitro assays to identify antibiotics that are cytotoxic to normal equine chondrocytes and synovial cells.. Equine Vet J 2021 May;53(3):579-589.
    doi: 10.1111/evj.13314pmc: PMC7738387pubmed: 32544273google scholar: lookup
  24. Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro.. Clin Orthop Relat Res 2007 Sep;462:200-6.
    doi: 10.1097/BLO.0b013e31811ff866pubmed: 17572634google scholar: lookup
  25. Mills ML, Rush BR, St Jean G, Gaughan EM, Mosier D, Gibson E, Freeman L. Determination of synovial fluid and serum concentrations, and morphologic effects of intraarticular ceftiofur sodium in horses.. Vet Surg 2000 Sep-Oct;29(5):398-406.
    doi: 10.1053/jvet.2000.9141pubmed: 10999453google scholar: lookup
  26. Newman JC, Prange T, Jennings S, Barlow BM, Davis JL. Pharmacokinetics of tobramycin following intravenous, intramuscular, and intra-articular administration in healthy horses.. J Vet Pharmacol Ther 2013 Dec;36(6):532-41.
    doi: 10.1111/jvp.12048pubmed: 23531033google scholar: lookup
  27. Sanchez Teran AF, Rubio-Martinez LM, Villarino NF, Sanz MG. Effects of repeated intra-articular administration of amikacin on serum amyloid A, total protein and nucleated cell count in synovial fluid from healthy horses.. Equine Vet J Suppl 2012 Dec;(43):12-6.
  28. Stover SM, Pool RR. Effect of intra-articular gentamicin sulfate on normal equine synovial membrane.. Am J Vet Res 1985 Dec;46(12):2485-91.
    pubmed: 4083580
  29. Lescun TB, Adams SB, Wu CC, Bill RP, Van Sickle DC. Effects of continuous intra-articular infusion of gentamicin on synovial membrane and articular cartilage in the tarsocrural joint of horses.. Am J Vet Res 2002 May;63(5):683-7.
    doi: 10.2460/ajvr.2002.63.683pubmed: 12013469google scholar: lookup
  30. Davenport CL, Boston RC, Richardson DW. Effects of enrofloxacin and magnesium deficiency on matrix metabolism in equine articular cartilage.. Am J Vet Res 2001 Feb;62(2):160-6.
    doi: 10.2460/ajvr.2001.62.160pubmed: 11212020google scholar: lookup
  31. Egerbacher M, Edinger J, Tschulenk W. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture.. Am J Vet Res 2001 May;62(5):704-8.
    doi: 10.2460/ajvr.2001.62.704pubmed: 11341389google scholar: lookup
  32. Bolt DM, Ishihara A, Weisbrode SE, Bertone AL. Effects of triamcinolone acetonide, sodium hyaluronate, amikacin sulfate, and mepivacaine hydrochloride, alone and in combination, on morphology and matrix composition of lipopolysaccharide-challenged and unchallenged equine articular cartilage explants.. Am J Vet Res 2008 Jul;69(7):861-7.
    doi: 10.2460/ajvr.69.7.861pubmed: 18593234google scholar: lookup
  33. Bohannon LK, Owens SD, Walker NJ, Carrade DD, Galuppo LD, Borjesson DL. The effects of therapeutic concentrations of gentamicin, amikacin and hyaluronic acid on cultured bone marrow-derived equine mesenchymal stem cells.. Equine Vet J 2013 Nov;45(6):732-6.
    doi: 10.1111/evj.12045pubmed: 23448189google scholar: lookup
  34. Knych HK, Mama KR, Moore CE, Hill AE, McKEMIE DS. Plasma and synovial fluid concentrations and cartilage toxicity of bupivacaine following intra-articular administration of a liposomal formulation to horses.. Equine Vet J 2019 May;51(3):408-414.
    doi: 10.1111/evj.13015pubmed: 30182426google scholar: lookup
  35. Ma J, Wang SS, Lin YZ, Liu HF, Liu Q, Wei HM, Wang XF, Wang YH, Du C, Kong XG, Zhou JH, Wang X. Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain.. Vet Res 2014 Aug 9;45(1):82.
    doi: 10.1186/s13567-014-0082-ypmc: PMC4283155pubmed: 25106750google scholar: lookup
  36. Rasband W. Image J, U.S. (1997–2018). Bethesda, MD: National Institutes of Health; (2018).
  37. Denney W, Duvvuri S, Buckeridge C. Simple, automatic noncompartmental analysis: the PKNCA R package. J Pharmacokinet Pharmacodyn (2015) 42:11–107.
    doi: 10.1007/s10928-015-9432-2google scholar: lookup
  38. Murphy PS, Wang J, Bhagwat SP, Munger JC, Janssen WJ, Wright TW, Elliott MR. CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages.. Cell Death Differ 2017 Mar;24(3):559-570.
    doi: 10.1038/cdd.2016.159pmc: PMC5344214pubmed: 28060378google scholar: lookup
  39. Dowling P. Antimicrobial therapy. Equine Clinical Pharmacology Philadelphia: W.B Saunders Co. (2004). p. 13–48.
  40. Adamson PJ, Wilson WD, Hirsh DC, Baggot JD, Martin LD. Susceptibility of equine bacterial isolates to antimicrobial agents.. Am J Vet Res 1985 Feb;46(2):447-50.
    pubmed: 3994111
  41. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation.. Nat Rev Immunol 2010 Jun;10(6):427-39.
    doi: 10.1038/nri2779pubmed: 20498669google scholar: lookup
  42. Rinnovati R, Bonelli F, Tognetti R, Claudio G, Rinaldo F, Veronica M. Effect of repeated arthrocentesis on cytology of synovial fluid. J Equine Vet Sci (2017) 57:112–5.
  43. Nocera I, Vitale V, Poli A, Bonelli F, Sgorbini M. Comparison between synovial fluid cytology and joint capsule histopathology in horses with chronic osteochondritis dissecans. Large Anim Rev (2019) 25:231–4.
  44. Walton RM, Cowell RL, Valenciano AC. Equine Hematology, Cytology, and Clinical Chemistry. Hoboken, NJ: Wiley-Blackwell; (2020).
  45. Anderson JR, Phelan MM, Clegg PD, Peffers MJ, Rubio-Martinez LM. Synovial Fluid Metabolites Differentiate between Septic and Nonseptic Joint Pathologies.. J Proteome Res 2018 Aug 3;17(8):2735-2743.
  46. Frisbie DD, Cross MW, McIlwraith CW. A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee.. Vet Comp Orthop Traumatol 2006;19(3):142-6.
    doi: 10.1055/s-0038-1632990pubmed: 16971996google scholar: lookup
  47. McIlwraith CW, Fortier LA, Frisbie DD, Nixon AJ. Equine Models of Articular Cartilage Repair.. Cartilage 2011 Oct;2(4):317-26.
    doi: 10.1177/1947603511406531pmc: PMC4297134pubmed: 26069590google scholar: lookup
  48. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis.. Bone Joint Res 2012 Nov;1(11):297-309.
  49. Chu CR, Szczodry M, Bruno S. Animal models for cartilage regeneration and repair.. Tissue Eng Part B Rev 2010 Feb;16(1):105-15.
    doi: 10.1089/ten.teb.2009.0452pmc: PMC3121784pubmed: 19831641google scholar: lookup
  50. Reesink HL, Watts AE, Mohammed HO, Jay GD, Nixon AJ. Lubricin/proteoglycan 4 increases in both experimental and naturally occurring equine osteoarthritis.. Osteoarthritis Cartilage 2017 Jan;25(1):128-137.
    doi: 10.1016/j.joca.2016.07.021pmc: PMC5489058pubmed: 27498214google scholar: lookup
  51. Frisbie DD, Kawcak CE, Trotter GW, Powers BE, Walton RM, McIlwraith CW. Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model.. Equine Vet J 1997 Sep;29(5):349-59.
  52. Gilbertie JM, Schnabel LV, Hickok NJ, Jacob ME, Conlon BP, Shapiro IM, Parvizi J, Schaer TP. Equine or porcine synovial fluid as a novel ex vivo model for the study of bacterial free-floating biofilms that form in human joint infections.. PLoS One 2019;14(8):e0221012.
  53. Coakley G, Mathews C, Field M, Jones A, Kingsley G, Walker D, Phillips M, Bradish C, McLachlan A, Mohammed R, Weston V. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults.. Rheumatology (Oxford) 2006 Aug;45(8):1039-41.
    doi: 10.1093/rheumatology/kel163apubmed: 16829534google scholar: lookup
  54. Wright IM, Smith MR, Humphrey DJ, Eaton-Evans TC, Hillyer MH. Endoscopic surgery in the treatment of contaminated and infected synovial cavities.. Equine Vet J 2003 Sep;35(6):613-9.
    doi: 10.2746/042516403775467225pubmed: 14515964google scholar: lookup

Citations

This article has been cited 5 times.
  1. Zhao N, Curry D, Evans RE, Isguven S, Freeman T, Eisenbrey JR, Forsberg F, Gilbertie JM, Boorman S, Hilliard R, Dastgheyb SS, Machado P, Stanczak M, Harwood M, Chen AF, Parvizi J, Shapiro IM, Hickok NJ, Schaer TP. Microbubble cavitation restores Staphylococcus aureus antibiotic susceptibility in vitro and in a septic arthritis model. Commun Biol 2023 Apr 17;6(1):425.
    doi: 10.1038/s42003-023-04752-ypubmed: 37069337google scholar: lookup
  2. Vajs T, Nekouei O, Biermann NM. A Descriptive Study of the Clinical Presentation, Management, and Outcome of Horses with Acute Soft Tissue Trauma of the Tarsus and the Association with Synovial Involvement. Animals (Basel) 2022 Feb 21;12(4).
    doi: 10.3390/ani12040524pubmed: 35203232google scholar: lookup
  3. Willette JA, Tsoi M, Frobish D, VanderBroek AR. Intrathecal enalapril reduces adhesion formation in experimentally induced digital flexor tendon sheath injuries in horses. Vet Surg 2025 Jan;54(1):141-154.
    doi: 10.1111/vsu.14186pubmed: 39498787google scholar: lookup
  4. Wheat W, Chow L, Still-Brooks K, Moore-Foster R, Herman J, Hunter R, Garry F, Dow S. Immune modulatory effects of tulathromycin, gamithromycin, and oxytetracycline in cattle. BMC Vet Res 2024 Oct 9;20(1):456.
    doi: 10.1186/s12917-024-04254-xpubmed: 39385141google scholar: lookup
  5. Post HK, Blankespoor MG, Ierulli VK, Morey TD, Schroeppel JP, Mulcahey MK, Vopat BG, Vopat ML. Review of Intra-Articular Use of Antibiotics and Antiseptic Irrigation and Their Systematic Association with Chondrolysis. Kans J Med 2023;16(3):272-276.
    doi: 10.17161/kjm.vol16.20357pubmed: 37954883google scholar: lookup